Table 1.
Demographic and clinical data of patient subjects.
Demographic Data: | n | Minimum | Maximum | Mean | SD | Median | ||
---|---|---|---|---|---|---|---|---|
Gender | ||||||||
male | 213 | |||||||
female | 215 | |||||||
Age [years] | 428 | 20 | 94 | 71.59 | 12.33 | 72.50 | ||
Height [cm] | 423 | 136 | 181 | 157.61 | 8.56 | 158.00 | ||
Weight [kg] | 421 | 30 | 110 | 50.56 | 11.07 | 50.00 | ||
Diagnosis (primary disease): | n | Diagnosis (primary disease): | n | |||||
lung cancer | 81 | breast cancer | 60 | |||||
stomach cancer | 26 | pancreas cancer | 25 | |||||
prostate cancer | 25 | colon cancer | 22 | |||||
bladder cancer | 17 | rectal cancer | 13 | |||||
hepatocellular cancer | 12 | esophageal cancer | 10 | |||||
uterus cancer | 9 | ovary cancer | 8 | |||||
others | 120 | |||||||
Status and side effects: | absence | presence | ||||||
somatic pain | 38 | 390 | ||||||
visceral pain | 346 | 82 | ||||||
neuropathic pain | 327 | 101 | ||||||
nausea | 193 | 138 | ||||||
constipation | 113 | 245 | ||||||
Breakdown of opioids: | n | morphine | oxicodone | fentanyl | tapentadol | tramadol | methadone | hydromorphone |
Number of administered patients | 426 | 97 | 209 | 107 | 10 | 31 | 5 | 41 |
Administration of opioids: | n | Minimum | Maximum | Mean | SD | Median | ||
Total dose of opioids [mg/kg] | 419 | 0.060241 | 32.407407 | 1.74 | 3.09 | 0.8163265 | ||
(converted to oral morphine) | ||||||||
Administration of other drugs: | absence | presence | ||||||
NSAIDs | 137 | 291 | ||||||
supplementary analgesics | 171 | 257 |